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ABSTRACT
Functional movement disorders (FMD) are proposed 
to reflect a specific problem with voluntary control of 
movement, despite normal intent to move and an intact 
neural capacity for movement. In many cases, a positive 
diagnosis of FMD can be established on clinical grounds. 
However, the diagnosis remains challenging in certain 
scenarios, and there is a need for predictors of treatment 
response and long- term prognosis.
In this context, we performed a systematic review of 
biomarkers in FMD. Eighty- six studies met our predefined 
criteria and were included.
We found fairly reliable electroencephalography and 
electromyography- based diagnostic biomarkers for 
functional myoclonus and tremor. Promising biomarkers 
have also been described for functional paresis, gait 
and balance disorders. In contrast, there is still a 
lack of diagnostic biomarkers of functional dystonia 
and tics, where clinical diagnosis is often also more 
challenging. Importantly, many promising findings focus 
on pathophysiology and reflect group- level comparisons, 
but cannot differentiate on an individual basis. Some 
biomarkers also require access to time- consuming and 
resource- consuming techniques such as functional MRI.
In conclusion, there are important gaps in diagnostic 
biomarkers in FMD in the areas of most clinical 
uncertainty. There is also is a lack of treatment response 
and prognostic biomarkers to aid in the selection of 
patients who would benefit from rehabilitation and other 
forms of treatment.
INTRODUCTION
Functional movement disorders (FMD) are 
common and often disabling.1 2 Their diagnosis was 
traditionally based on the exclusion of ‘organic’ 
conditions and on the presence of psychological 
trauma. However, current criteria emphasise estab-
lishing a diagnosis based on positive criteria from 
history and examination, such as eliciting distracti-
bility or entrainment of functional tremor.3 In addi-
tion, a ‘laboratory supported’ diagnostic category 
has been suggested, where specific investigations 
provide additional diagnostic certainty.4 5 Recent 
years have seen an increasing interest in treatment 
of FMD, with consensus criteria published for 
physiotherapy treatment, and positive results from 
cohort and randomised trials of physiotherapy and 
multidisciplinary rehabilitation.6–9
However, a number of important challenges 
remain in diagnosis and treatment. First, diagnosis is 
not always straightforward, and there are particular 
clinical scenarios, for example, dystonic posturing, 
overlay of functional symptoms on an underlying 
organic movement disorder, where diagnosis can be 
particularly difficult.10 Second, treatment studies, 
while often positive, all show a range of treat-
ment response with a proportion of people having 
no improvement. However, prediction of likely 
response to treatment is difficult. For example, 
in two studies of inpatient multidisciplinary reha-
bilitation for severely affected people, no reliable 
baseline predictors of treatment response were 
found.11 12 This is particularly problematic given 
the expensive and time- consuming nature of this 
treatment. Third, a proportion of patients recover 
without treatment, while some will remain with 
symptoms lifelong, but there are no reliable ways of 
determining prognosis at first presentation. If there 
were, then it would be helpful for stratifying and 
prioritising patients for treatment. Fourth, in devel-
opment of novel treatments, we do not have reliable 
markers of subclinical response to treatment, some-
thing that could be helpful in determining that a 
treatment shows promise for further development.
In other illnesses, these challenges are typically 
addressed through the search for biomarkers. There 
are different types of biomarkers depending on 
the purpose. The Biomarker Definitions Working 
Group13 defines four main types of biomarkers:
1. Biomarkers used as a diagnostic tool for iden-
tifying patients with a disease or abnormal 
condition.
2. Biomarkers used as a tool for staging a disease 
or classifying the extent of disease.
3. Biomarkers used as an indicator of disease prog-
nosis.
4. Biomarkers used for predicting and monitoring 
the clinical response of an intervention—re-
sponse biomarkers.14
We performed a systematic review to characterise 
the current state of biomarker development in FMD, 
and to identify key gaps and challenges in order to 
define a roadmap of priorities for future research.
METHOD
For this systematic review, we first created a PubMed 
search term list that can be found in the online supple-
mental materials. A search on PubMed performed 
on 28 February 2019 revealed 1137 studies. We 
also hand searched reference lists of selected arti-
cles. The inclusion criteria were: human subjects; 
original studies; studies investigating the (measur-
able) biological correlates of abnormal movement 
in FMD; and literature in English. Our exclusion 
criteria were: sample size smaller than three partic-
ipants; and studies investigating comorbidities, for 
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example, abnormal emotional processing. BLCT first identified 
and retrieved all original studies which could be relevant, based 
on title and abstract. BLCT and TT then independently anal-
ysed the retrieved articles and selected studies that fulfilled the 
inclusion/exclusion criteria. Disagreements were discussed with 
MJE and resolved based on consensus. Study quality assessment 
was based on the size of the groups considered the sample size, 
inclusion of a control group and blinding. We performed a qual-
itative analysis and narrative synthesis per biomarker, method of 
measurement and movement disorder phenotype.
This study protocol was registered on PROSPERO with the 
registration number CRD42019127554.
RESULTS
Eighty- six studies were selected for the qualitative analysis 
(figure 1 and online supplemental table 1). The most promising 
diagnostic biomarkers are summarised in table 1.5 15–21
Functional tremor
Neurophysiological biomarkers
Electromyography (EMG) and accelerometery have been used 
to define the neurophysiological characteristics of functional 
Figure 1 Flow chart of study identification. Flow diagram of the study 
identification and selection.
Table 1 Potential diagnostic biomarkers in functional movement disorders




Tremor         
Test battery5 EMG and accelerometer 
recordings of upper limbs 
in relaxed condition, 
outstretched with and 
without weight loading, 
during tapping tasks and 






Other type of 
organic tremor: 11
High sensitivity and 
specificity differentiating 




Unknown value for 
differentiating pure 
functional tremor from 
functional overlay; 
functional tremor can be 
diagnosed clinically with 
high- level confidence in 
most patients.
90% 96% 92%
Myoclonus           
Bereitschaftspotential 






EEG is widely available.
76% 100% 100%
Paresis         
EMG activity16 EMG of the affected hand 
while performing finger 






High sensitivity and 
specificity.




Measuring force of 
involuntary and voluntary 
hip flexion in Hoover’s test. 






Paresis due to 
pain (lumbar 
radiculopathy): 9
High sensitivity and 
specificity of ‘Hoover’s 
index’ (cut- off 1.4) in 
differentiating functional 
paresis from both organic 
paresis and feigners.
Uncertain advantage in 
comparison to standard 
Hoover’s test.
100% 100% 100%
Mixed         
A model of functional 
connectivity19
Resting state fMRI. 
Hyperconnected right caudate, 
left amygdala and bilateral 
postcentral gyri. Decreased 
functional connectivity in the 




Usable in a mixed group 
of FMD.
Only compared with 
healthy controls and 
not organic movement 
disorders.
Expensive and not 
accessible in every 
hospital.
70% 68% Diagnostic 
accuracy: 
69%21
Body sway20 Trunk inclination in 
transverse plane and body 
angular velocity measured 






Can differentiate FMD 
from both organic disease 
and healthy controls.
The equipment is not 
widely available.
100% 100% 100%
The most promising potential biomarkers for different phenotypes of functional movement disorders.
EEG, electroencephalography; EMG, electromyography; FMD, functional movement disorder; fMRI, functional MRI.
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tremor and also tested as a diagnostic tool.4 5 22–32 Functional 
tremor is characterised by a large variation of tremor amplitude 
and frequency,24–26 28–30 32 tonic discharge of antagonist muscles 
shortly before tremor onset4 5 30 (sensitivity 46%–100%, speci-
ficity 96%–100%4 5 30), higher amplitude during loading4 5 22 24 30 
(sensitivity 33%–69%, specificity 75%–95%4 22 30), changes in 
frequency during distraction22 24 28 30 (sensitivity 42%–92% and 
specificity of 94%22 28 30), entrainment4 5 22 24 27 29 (sensitivity 
39%–91%, specificity 91%–100%4 22 29), less accuracy in tapping 
performances4 5 (sensitivity 46%, specificity 84%4), reduction 
of amplitude or cessation when performing ballistic movement 
with the opposite hand4 5 23 (sensitivity 67%–100%, specificity 
84%–100%4 23), significant coherence between the two hands in 
bilateral tremor4 5 29 (sensitivity 56%, specificity 96%4), higher 
number of periods without significant coherence,31 absence of 
finger tremor30 (sensitivity of 100%30) and involving fewer limb 
segments.29 Algorithms including these neurophysiological and 
behavioural variables have shown a sensitivity of 87%–100% and 
specificity of 93%–100%.4 5 26
One EMG study investigating coherence in muscle pairs 
(extensors and flexors) and cumulant analysis (assessing timing 
between EMG bursts in muscle pairs) in patients with functional 
tremor and different phenotypes of organic tremor found that 
these methods could be useful in differentiating some types 
of organic tremor but not for diagnosing functional tremor.25 
Another study observed that some patients with functional hand 
tremor showed tremor coherence between their hands whereas 
other patients showed independent oscillations. The latter might 
be explained by coexisting non- functional tremulous muscle 
activity such as clonus or enhanced physiological tremor.33
Functional neuroimaging biomarkers
Patients with functional tremor have shown increased activity in 
the motor/emotion- processing circuits in the anterior cingulate/
paracingulate cortex. This activation decreased in the patients 
who improved after cognitive–behavioural therapy.34
A decrease in the activation of the right temporoparietal junc-
tion (rTPJ) during functional tremor has been reported. Reduced 
activation of the rTPJ might relate to patients’ experience of lack 
of sense of agency over their movements.35
A single- photon emission CT (SPECT) study described higher 
relative cerebral blood flow (rCBF) in the left inferior frontal 
gyrus (IFG) and left insula at rest. During motor tasks, increased 
rCBF was observed in the cerebellum, and reduced rCBF in 
the medial prefrontal cortex and anterior cingulate cortex, as 
compared with the resting state.36
Behavioural biomarkers
Patients with functional tremor performed a reaction time test 
with one hand while the other hand was either at rest or trem-
bling. Reaction time was prolonged when the opposite hand was 
trembling, as compared with resting, suggesting a dual task effect 
in people with functional tremor that was absent in people with 
‘organic’ tremors.37 During a self- paced movement task, patients 
with functional tremor showed a delayed perception of their 
intention to move as compared with healthy controls. This was 
proposed to reflect a loss of sense of agency over movement.38
Functional dystonia
Neurophysiological biomarkers
Contrary to patients with organic dystonia, subjects with func-
tional mobile- type dystonia as well as those with fixed dystonia 
associated with complex regional pain syndrome have shown 
normal sensorimotor plasticity.39–41
Functional fixed dystonia has shown fewer co- contractions on 
EMG as compared with fixed dystonia secondary to structural 
damage.42 Electrophysiological measures of cortical and spinal 
inhibition were abnormal in both fixed and organic dystonia, but 
with considerable variability between individuals.43 44
Functional neuroimaging biomarkers
A positron emission tomography (PET) study found that during 
a motor task, patients with functional dystonia had increased 
activity in the cerebellum and basal ganglia and decreased 
activity in primary motor cortex as compared with healthy 
controls and patients with organic dystonia. When comparing 
activity at rest and during motor tasks, increased activity was 
found in the dorsolateral prefrontal cortex in patients with both 
functional and organic dystonia. These results were proposed to 
reflect disturbances in motor attention in both functional and 
organic dystonia.45
Structural neuroimaging biomarkers
A structural MRI study reported subtle signs of atrophy in 
subjects with mobile functional dystonia, involving a wide range 
of areas involved in sensorimotor processing, emotional and 
cognitive control. In addition, functional fixed dystonia was 
associated with a disruption of fibre architecture of white matter 
tracts.46
Behavioural biomarkers
Patients with functional dystonia and primary generalised 
dystonia have both shown an increase in temporal discrimina-
tion thresholds as compared with healthy controls.47 However, 
a second study failed to replicate this finding for functional 
dystonia.48
Mental rotation is impaired in patients with functional 
dystonia and organic dystonia.48 Patients with functional dystonia 
were observed to have shorter reaction times as compared with 
patients with secondary dystonia, but with considerable overlap 
between the two groups.42
Functional myoclonus
Neurophysiological biomarkers
The Bereitschaftspotential (BP), or premovement potential, is a 
slow- rising potential seen in the electroencephalography (EEG) 
starting about a second before a self- paced movement. It appears 
to start in the supplementary motor area (SMA), which is there-
fore thought to have a role in the initiation of voluntary move-
ment.49 Studies have shown that BP is present in 25%–86% of 
patients with functional myoclonus,15 50–54 and has a specificity of 
100% in differentiating functional and organic myoclonus.15 50 51 
Intriguingly, the absence of a BP prior to a voluntary self- paced 
movement had a sensitivity of 59% and a specificity of 98% to 
differentiate functional myoclonus from organic myoclonus and 
Tourette’s syndrome.51 The amplitude of beta and low gamma 
oscillations (13–45 Hz) normally reduces prior to cued and self- 
paced movements.55 This phenomenon is called ‘event related 
desynchronisation’ and can also be measured with an EEG. The 
presence of event- related desynchronisation had a sensitivity of 
62%–65%15 50 and a specificity of 100% for diagnosing func-
tional myoclonus.15 50 51 Combined BP and event- related desyn-
chronisation had a sensitivity of 75%–80% and a specificity of 
100% in differentiating functional and organic myoclonus.15 50
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An ‘incongruent EMG’ was observed in 85% of a group of 
patients with functional myoclonus, and was also proposed to 
have diagnostic value.53 56 An ‘incongruent EMG’ was defined 
by an inconsistent pattern of muscle involvement,56 differing 
from the EMG findings described for propriospinal myoclonus 
by Brown et al.57 In a cohort including 34 patients with func-
tional myoclonus all showed either a BP or an incongruent 
EMG, suggesting a sensitivity of 100% for this combination of 
biomarkers.53
An EMG study investigating auditory startle responses 
showed increased response probability in functional myoclonus, 




In patients with unilateral paresis of an upper limb, finger abduc-
tion in the non- affected hand resulted in synkinetic activity 
detected by EMG on the affected hand in all patients with func-
tional paresis, but none in organic paresis. This corresponds to 
a sensitivity and specificity of 100% in differentiating functional 
and organic paresis.16
Motor- evoked potentials (MEP) induced by transcranial 
magnetic stimulation during voluntary muscle contractions in 
healthy controls showed shorter latencies, increased amplitudes 
and a longer duration as compared with patients with functional 
paresis.59 During a cued reaction time task, patients with func-
tional paresis showed a larger intrasubject variation of MEP 
amplitudes, as compared with healthy controls and patients with 
amyotrophic lateral sclerosis. This parameter had high speci-
ficity for functional paresis.60
The MEP amplitude during motor imagery (subjects imagining 
performing a movement) was observed to increase by 200% in 
healthy controls but only by 63% in the non- paretic finger and 
37% in the paretic finger of patients with functional weakness.61 
In healthy controls, motor imagery resulted in an increase in 
corticospinal excitability while patients with functional paresis 
showed a decrease.62 63 However, during motor observation 
(watching a video of a person performing a movement) normal 
MEPs were seen, suggesting that moving focus of attention away 
from the patient might be a useful therapeutic approach.63
Contingent negative variation is an EEG signal detected in the 
waiting period between a preparation cue to move and the ‘go’ 
cue. In a precued reaction time task, patients with functional 
paresis and healthy controls feigning paresis showed similar 
force reductions, slowing movement and prolongation of muscle 
activity as compared with healthy controls instructed to move 
normally. However, a reduced contingent negative variation 
was only seen in patients and not in healthy controls feigning 
paresis.64
In a precued reaction time task, patients with functional 
weakness showed larger P3 event- related potentials when their 
symptomatic hands were precued as well as smaller earlier N1 
potentials in comparison with feigning subjects. The authors 
proposed that the abnormal N1 could reflect abnormal 
processing of precues, and the enhancement of P3 could be 
related with the suppression of brain circuits involved in the 
attribution of agency.65
A study using a two- choice reaction task found that the event- 
related potentials in the anterior cingulate cortex were hyper-
active during movements of the paretic arm compared with the 
non- affected arm.66
Using isometric measures, a large variability of torque force 
was seen in patients with functional paresis. Furthermore, there 
was a relative decrease in the torque force, which was stronger 
in fast as compared with slow movements.67
Functional neuroimaging biomarkers
A functional MRI (fMRI) study reported that patients with func-
tional paresis showed hyperactivity in the left amygdala during 
simultaneous emotional stimulation (pictures of sad faces) and 
passive movement. Furthermore, increased functional connec-
tivity was found between the left amygdala and the (pre- )SMA 
and subthalamic nucleus. These results suggested a link between 
abnormal emotional processing and impaired motor control in 
functional paresis.68
fMRI during passive movement of an upper limb with func-
tional weakness or feigned weakness showed increased activity 
in the IFG as compared with non- feigning healthy controls.69
Another fMRI study reported abnormal patterns of activity 
in the prefrontal and parietal areas, supramarginal gyrus and 
precuneus in patients with functional paresis as compared with 
feigning and non- feigning healthy controls.70
An increased functional connectivity between the dorsolateral 
prefrontal cortex and sensorimotor areas was observed during 
imagined movement of the paretic hand, as compared with the 
non- paretic hand.71 Furthermore, there were abnormalities in the 
functional connectivity within the default mode network, as well 
as between the default mode network and other areas/networks 
involved in memory, emotion, self- referential processing, motor 
planning and execution.72
During movement, both patients with functional paresis and 
healthy controls feigning paresis showed smaller activation of 
the motor cortex contralateral to the affected limb. However, 
patients also showed a more widespread pattern of abnormal 
cortical activity.73
Motor imagery of the affected paretic upper limb was associ-
ated with an activation of the frontal cortex, superior temporal 
cortex and the gyrus rectus.74 75 Patients with functional hemi-
paresis showed a reduced activity during motor imagery in the 
cortical hand areas contralateral to the paresis.76
Regional homogeneity is an fMRI parameter which inves-
tigates the functional network by measuring the coherence of 
spontaneous low- frequency signal fluctuations in the brain. 
The regional homogeneity was increased in the left precentral 
gyrus and reduced in the precuneus contralateral to the paresis. 
In addition, patients with functional weakness have shown a 
prolongation of the short- interval intracortical inhibition facili-
tation, which is a parameter of sensorimotor integration.77
A SPECT study demonstrated that during vibratory stim-
ulation, patients had reduced rCBF in the thalamus and basal 
ganglia contralateral to the paresis. Importantly, this abnormal 
pattern of activity normalised after clinical recovery suggesting 
that it might reflect a reversible impairment of sensorimotor 
function.78
Finally, a PET study found a decreased rCBF in frontal regions 
in patients with functional hemiparesis.79
Structural neuroimaging biomarkers
A structural MRI study reported a reduced volume of the left 
thalamus as compared with healthy controls. However, this rela-
tive atrophy could either be a cause or a consequence of limb 
paresis.80 Another study found a bilateral increased grey matter 
thickness of the premotor cortex, but only in patients with func-
tional hemiparesis and not in paraparesis.81
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Behavioural biomarkers
Hoover’s sign is the most useful clinical manoeuvre to establish a 
positive diagnosis of functional paresis of the lower limb.82 Two 
studies investigated quantitative versions of the Hoover’s test, 
based on the measurement of isometric force of hip extension 
performed during direct maximal voluntary effort and contra-
lateral hip flexion. The authors defined ‘Hoover’s index’ as 
involuntary/voluntary force ratio on the affected limb as well as 
‘side ratios’, corresponding to the ratios of ‘involuntary/volun-
tary ratios’ between affected and unaffected limbs. These studies 
reported increases in the Hoover’s index of the limbs with 
functional weakness (sensitivity and specificity of 100% using 
a cut- off value of 1.4) as well as increases in the ‘side ratios’, 
as compared with healthy controls and patients with organic 
paresis.17 18
Patients with functional paresis have shown greater increases 
in muscle power during eccentric compared with static contrac-
tions as well as during encouragement (sensitivity of 100% and 
specificity of 67%).83 Finally, functional paresis has been associ-
ated with prolonged reaction times but normal response dura-
tions, suggesting an impairment of motor initiation.84
Mixed FMDs
Several studies included phenotypically mixed groups of patients 
with FMD which will be reviewed in this section. Studies of 
functional gait and balance disorders will also be reported here.
Neurophysiological biomarkers
Patients with FMD lacked the normal decrease in the ampli-
tude of the sensory- evoked potentials that occurs at the onset of 
self- paced voluntary movement. This finding was proposed to 
reflect an impairment of sensory attenuation.85 During a precued 
reaction time task, patients failed to take advantage from highly 
predictive cues to improve reaction times, in contrast to healthy 
controls. This abnormal motor performance was accompanied 
by an impairment of the beta desynchronisation and lateralisa-
tion during motor preparation, which was proposed to reflect 
abnormal attention.86
Functional neuroimaging biomarkers
A resting state fMRI study in patients with FMD reported 
increased connectivity between right caudate, left amygdala 
and bilateral postcentral gyri as well as decreased connectivity 
between the rTPJ and frontal regions. A model, built from these 
data, to distinguish FMD from healthy controls had a sensitivity 
of 70%, specificity of 68% and diagnostic accuracy of 69%.19 21 
Another study found decreased functional connectivity between 
the rTPJ and the right sensorimotor cortex, cerebellar vermis, 
bilateral SMA and right insula.87 fMRI during a motor task in a 
virtual reality setting where hand movements could be mimicked 
with high, intermediate or low accuracy showed a more restricted 
pattern of activation in patients with FMD (circumscribed to the 
right anterior insula and rTPJ), and this pattern was related with 
the abnormal sense of agency.88
During a two- button action selection task, patients with FMD 
showed hypoactivity in the left SMA in both internally and 
externally generated movements, which suggests a reduced top- 
down regulation from higher order regions. Hyperactivity of the 
right amygdala, left anterior insula and bilateral posterior cingu-
late was proposed to reflect abnormal limbic activation during 
motor initiation.89
During a visuomotor task consisting of drawing a straight line 
while the computer created deviations, subjects were asked to 
rate the deviations and confidence in their responses. Healthy 
subjects activated the left superior precuneus and middle 
temporal area, which are involved in sensorimotor integration 
and vision, whereas patients with FMD activated the bilateral 
parahippocampal and amygdalohippocampal regions, which 
have a role in processing memory, associative processing and 
emotion.90 fMRI performed during a motor task with emotional 
stimulation (exposure to pleasant and unpleasant pictures) 
showed increased activity in the inferior frontal cortex and pre- 
SMA in healthy controls but increased activity in the cerebellum, 
posterior cingulate cortex and hippocampus suggesting a defen-
sive mechanism.91
Structural neuroimaging biomarkers
Patients with FMD showed increased volume of the left amyg-
dala, striatum, cerebellum, fusiform gyrus and bilateral thalamus 
as well as a decreased volume in the left sensorimotor cortex.92 
In addition, another study described a decreased volume of the 
bilateral caudate nuclei, lentiform nuclei and right thalamus.93
Behavioural biomarkers
In a go/no- go task, patients with FMD showed an impairment 
of motor response inhibition.94 Patients with FMD reported 
an auditory tone as happening earlier and the motor action as 
happening later compared with trials where they were only 
asked to report the timing of the effect (auditory tone) or 
action. Overall, the binding scores were lower in patients as 
compared with healthy controls related to a reduced experience 
of control.95
Patients with FMD showed a larger startle response when 
looking at both positive and negative pictures as compared 
with neutral pictures, while healthy controls only showed larger 
startle responses when watching negative pictures.96 In patients 
with FMD there was a decreased force output only when looking 
at unpleasant pictures, while healthy controls showed a decrease 
for both pleasant and unpleasant pictures.91
Body sway analysis using accelerometers revealed increased 
trunk inclination and angular velocity in patients with FMD 
(sensitivity 92% and specificity 92%).20 97 Body sway can also 
be measured by standing on a force platform. Patients with 
functional paresis and gait disorders showed a larger worsening 
of their static balance after closing their eyes.98 Importantly, 
distraction produced a significant normalisation of the postural 
abnormalities in functional patients (sensitivity 100% and sensi-
tivity 100%).20 98 Finally, under a situation of mental stress, body 
sway was observed to decrease over time in healthy controls, but 
not in patients with FMD.97
DISCUSSION
Here we have presented the results of a systematic review of 
biomarkers in FMD. Though over 80 studies of relevance were 
found, there were very few that presented biomarkers that were 
validated or had undergone significant development in order to 
assess their potential utility.
There were two areas where diagnostic biomarkers were 
well established and validated in several independent patient 
cohorts: functional myoclonus and functional tremor. In func-
tional myoclonus the BP appears to be a robust biomarker for 
differentiating functional and organic myoclonus. Sensitivity 
was 25%–86% and the specificity was 100%.15 50–53 The lack of 
sensitivity may reflect the technical difficulty of recording BP 
in people with very frequent jerks as several seconds of EMG 
silence are needed for the EEG to stabilise, or very infrequent 
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jerks where insufficient data are acquired to allow visualisation 
of the BP. There is the suggestion that combining the BP with 
assessment of event- related beta desynchronisation (another 
EEG measure that can be derived from the same data set, and 
therefore not an additional procedure for the patient) increases 
sensitivity.15 50 Variability of EMG recruitment patterns is 
another potential marker of functional myoclonus.58 Indeed, as 
is the case for functional tremor, a combination of diagnostic 
biomarkers may be appropriate as a standard diagnostic toolkit 
for functional myoclonus.
In functional tremor, a range of electrophysiological measures 
have been found to have good sensitivity and specificity, many 
of these repeated across different cohorts in different laborato-
ries, which increases confidence in their reliability.4 5 22–32 In two 
linked studies a battery of these tests was assembled and applied 
to cohorts of patients with functional tremor and organic tremor, 
yielding a cut- off score for diagnosis of functional tremor 
with a sensitivity of 100% and a specificity of 100%.4 5 In the 
follow- up validation study these same measures were applied to 
a new cohort of patients, which confirmed the high sensitivity 
and specificity (90% and 96%, respectively).5 One unanswered 
question from these studies is the proportion of people with 
tremor where such tests would actually be necessary. Clinical 
examination is often sufficient to diagnose functional tremor, 
and it is likely that these tests will only be necessary for a small 
number of patients. They could be useful in particular contexts, 
for example, in a clinical trial setting, or in cases with suspected 
functional overlay, particularly when invasive procedures such 
as deep brain stimulation or thalamotomy are being considered.
Hoover’s sign is a well- established clinical sign in functional 
paresis. Two studies have developed quantitative versions of this 
manoeuvre, reporting a sensitivity and specificity of 100%.17 18 
One of the studies used a simple weighing scale to measure force, 
which makes the technique highly accessible.18 However, again, 
it remains to be determined which patients would require this 
quantitative technique as opposed to simply eliciting Hoover’s 
sign as part of physical examination. Notably, expert clinical 
assessment (including Hoover’s sign) is the gold standard against 
which quantitative techniques are validated. It may be that 
these techniques (as well as objective techniques for diagnosing 
tremor) may be useful as a tool to demonstrate the diagnosis to 
patients as part of diagnostic explanation, potentially enhancing 
diagnostic understanding compared with clinical demonstration 
alone.99
In unilateral functional arm paresis, a presentation which is 
not straightforward to diagnose clinically in some cases, abduc-
tion of the non- affected fingers resulted in synkinetic activity 
of the affected hand measured with EMG in one study. The 
test showed a 100% sensitivity and specificity in differentiating 
functional and organic paresis, and would benefit from further 
validation.16 In another upper limb measure using variability of 
movements in response to torque forces, 22 out of 25 patients 
performed abnormally, corresponding to a sensitivity of 88%.67 
However, this test requires specific equipment, limiting its clin-
ical generalisability, at least in the form reported.
Body sway analysis could help identifying patients with func-
tional gait and balance problems. Patients with functional gait or 
balance disturbance had a significantly higher angular velocity 
of the trunk inclination in the transverse plane which had a 
sensitivity and specificity of both 92%.20 97 A significantly better 
performance during distractions had a sensitivity and specificity 
of 100%.20 98 This finding is of interest given clinical difficul-
ties in some patients in diagnosis of functional gait and balance 
problems. While the methodology of the study requires the use 
of mobile accelerometers or force platforms, limiting its general-
isability to clinical practice, it is possible that it could be adapted 
for use with more readily available devices, for example, mobile 
phone- based apps that are increasingly available for measure-
ment of movement.
The clinical scenarios where diagnostic biomarkers are most 
needed are in functional dystonia and functional tics. There 
remains significant disagreement and uncertainty about the 
diagnosis of functional dystonia. The phenotypic qualities of 
organic tics (distractibility, suggestibility, suppressibility) make 
them complex to differentiate from functional tics, particularly 
in the setting of suspected functional overlay on top of Tourette’s 
syndrome. This has important ramifications for treatment, as 
invasive procedures become more widely used for treatment of 
refractory tics. We identified no studies that specifically looked 
for biomarkers for functional tics; the BP does not seem to be 
useful as it is quite commonly recorded in people with organic 
tics.
In functional dystonia sensorimotor plasticity was abnormal 
at a group level in organic dystonia but not in functional fixed 
or mobile dystonia.39 41 However, this measure is known to be 
highly variable in people with organic dystonia, and it is also 
not a measure that would be technically easy to implement into 
clinical practice.100
Functional neuroimaging techniques have mainly been used 
in studies focusing on pathophysiology but might also help 
identifying promising biomarkers. One potentially interesting 
diagnostic biomarker which is not linked to a specific pheno-
type was reported in a study of 23 patients with mixed FMD 
and 25 healthy controls using resting state fMRI. A model devel-
oped using the study data set to distinguish patients with FMD 
from healthy controls produced a sensitivity of 70% and a speci-
ficity of 68%. The model was based on hyperconnectivity in the 
right caudate, amygdala, prefrontal and sensorimotor regions.19 
There are problems of course in translating this into clinical 
practice methodologically, but resting state fMRI is not complex 
to acquire. The development of a diagnostic biomarker that is 
not linked to a specific phenotype is an attractive idea, and this 
study demonstrates that it may indeed be possible. Further work 
in this area would clearly be of interest.
Multiple studies have reported changes in the rTPJ 
and prefrontal areas which are related to sense of 
agency19 35 87 88 and disturbances in brain regions related to motor 
function.35 45 68 71–79 87 88 90 Increased activity has been demon-
strated in the cerebellum,36 45 91 basal ganglia,45 73 IFG,36 69 73 
insula,36 73 89 anterior cingulated cortex34 66 and limbic struc-
tures.68 89–91 However, although significant differences were 
found on a group level, it is not known to what extent they can 
differentiate at an individual patient level. These studies are also 
problematic for the inherent lack of generalisability of an fMRI 
measure to clinical practice. However, there may be certain 
situations where a functional neuroimaging biomarker could be 
used, for example, in the development of a novel medication or 
invasive treatment for FMD (eg, deep brain stimulation) where 
it is imperative to determine if there is some signal of a beneficial 
effect of treatment, as part of early- phase therapy development. 
Here, given the small number of subjects and the importance of 
detecting a therapeutic benefit, functional neuroimaging could 
be of use. However, the biomarker needed here would not be a 
diagnostic one, but instead a biomarker of treatment response.
Only a few studies investigated changes in biomarkers after 
treatment. One fMRI study described normalisation of hyper-
activity in the anterior cingulated/paracingulate cortex after 
successful cognitive–behavioural therapy.34 A SPECT study 
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reported normalisation of thalamic blood flow induced by 
peripheral vibratory stimulation after successful treatment.78 
Finally, we have recently reported that clinical improvement of 
FMD after neurophysiotherapy is associated with faster reaction 
times and with a normalisation of contingent negative variation 
during movement preparation, which was absent at baseline 
before treatment.101
Limitations of available evidence
Our review discussed several other potential diagnostic 
biomarkers, but none had undergone sufficient testing to recom-
mend them for current use. Most neuroimaging studies included 
very small sample sizes, often less than 10 subjects per group. 
Small sample sizes make it difficult or impossible to control for 
confounders. Moreover, the smaller the sample size, the larger 
the impact of heterogeneity among subjects with FMD in the 
final results. This might contribute to problems of replicability.
The most common clinical conundrum is differentiating 
patients with FMD from people with other causes of neurolog-
ical symptoms. However, a large proportion of studies only used 
healthy subjects as a control group.
There is still a major unmet need of identifying biomarkers 
capable of distinguishing functional neurological problems from 
factitious or malingering disorders in routine clinical practice. 
Only a few studies included control groups of healthy subjects 
instructed to feign, and it remains uncertain whether this consti-
tutes an appropriate control group for this purpose.
The development of biomarkers of FMD would also not 
necessarily solve the problem of identifying coexisting non- 
functional causes contributing for the motor symptoms—a 
frequent and often a greater challenge than the detection of 
functional elements.
Although we reviewed studies focusing on biomarker 
correlates of abnormal motor phenomena and excluded 
studies investigating non- motor comorbidities some changes 
detected in neuroimaging and neurophysiology may still reflect 
comorbidities.
We found no biomarkers that provided information on prog-
nosis. This is an issue of great importance in clinical practice. 
While there is now considerable evidence to support the use of 
physiotherapy and multidisciplinary rehabilitation in the treat-
ment of FMD, all treatment studies find a proportion of people 
who do not benefit. This is problematic, as multidisciplinary 
rehabilitation is time consuming and labour intensive and will 
only ever be a scarce resource. It would be a great benefit to be 
able to determine at baseline those patients who are most likely 
to respond to treatment. So far, clinical measures fail to predict 
those who do well or poorly with such treatment.11
The gold standard used for the validation of new diagnostic 
biomarkers in FMD is expert opinion based on clinical assess-
ment, and this creates a problem of ‘circularity’. In crude terms, 
this diagnostic strategy generates biomarkers that can only be 
as good as expert clinical opinion. As we improve our mecha-
nistic understanding of FMD it may be possible to shift towards 
objective biomarkers in clinical practice and also in research on 
biomarkers and treatment.
CONCLUSIONS
We found fairly reliable diagnostic biomarkers for functional 
myoclonus and to a lesser extend for tremor. However, there 
are major gaps in biomarker development for FMD. The most 
pressing clinical issues are for diagnostic biomarkers for func-
tional dystonia and tics, and for biomarkers capable of predicting 
prognosis and treatment response. Clues are available from 
the literature on the possible nature of these biomarkers. The 
potential benefits of strong diagnostic, predictive and prognostic 
biomarkers in FMD argue for a concerted internationally effort 
for biomarker development.
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“Conversion movement disorders”[All fields] OR “Conversive movement disorders”[All fields] OR “Dissociative movement 
disorders”[All fields] OR “Hysterical movement disorders”[All fields] OR “Functional motor disorder”[All fields] OR “Psychogenic 
motor disorder”[All fields] OR “Conversion motor disorder”[All fields] OR “Conversive motor disorder”[All fields] OR “Dissociative 
motor disorder”[All fields] OR “Hysterical motor disorder”[All fields] OR “Functional motor disorders”[All fields] OR “Psychogenic 
motor disorders”[All fields] OR “Conversion motor disorders”[All fields] OR “Conversive motor disorders”[All fields] OR 
“Dissociative motor disorders”[All fields] OR “Hysterical motor disorders”[All fields] OR “Hysteria”[All fields] OR "Conversion 
Disorder"[All fields] OR "Conversion Disorders"[All fields] OR “Functional Weakness”[All fields] OR “Psychogenic Weakness”[All 
fields] OR “Conversion Weakness”[All fields] OR “Conversive Weakness”[All fields] OR “Dissociative Weakness”[All fields] OR 
“Hysterical Weakness”[All fields] OR “Functional Paralysis”[All fields] OR “Psychogenic Paralysis”[All fields] OR “Conversion 
Paralysis”[All fields] OR “Conversive Paralysis”[All fields] OR “Dissociative Paralysis”[All fields] OR “Hysterical Paralysis”[All 
fields] OR “Functional Jerks”[All fields] OR “Psychogenic Jerks”[All fields] OR “Conversion Jerks”[All fields] OR “Conversive 
Jerks”[All fields] OR “Dissociative Jerks”[All fields] OR “Hysterical Jerks”[All fields] OR “Functional Myoclonus”[All fields] OR 
“Psychogenic Myoclonus”[All fields] OR “Conversion Myoclonus”[All fields] OR “Conversive Myoclonus”[All fields] OR 
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“Dissociative Myoclonus”[All fields] OR “Hysterical Myoclonus”[All fields] OR “Functional Tremor”[All fields] OR “Psychogenic 
Tremor”[All fields] OR “Conversion Tremor”[All fields] OR “Conversive Tremor”[All fields] OR “Dissociative Tremor”[All fields] 
OR “Hysterical Tremor”[All fields] OR “Functional Tics”[All fields] OR “Psychogenic Tics”[All fields] OR “Conversion Tics”[All 
fields] OR “Conversive Tics”[All fields] OR “Dissociative Tics”[All fields] OR “Hysterical Tics”[All fields] OR “Functional 
Dystonia”[All fields] OR “Psychogenic Dystonia”[All fields] OR “Conversion Dystonia”[All fields] OR “Conversive Dystonia”[All 
fields] OR “Dissociative Dystonia”[All fields] OR “Hysterical Dystonia”[All fields] OR “Functional Posture”[All fields] OR 
“Psychogenic Posture”[All fields] OR “Conversion Posture”[All fields] OR “Conversive Posture”[All fields] OR “Dissociative 
Posture”[All fields] OR “Hysterical Posture”[All fields] OR “Functional Postures”[All fields] OR “Psychogenic Postures”[All fields] 
OR “Conversion Postures”[All fields] OR “Conversive Postures”[All fields] OR “Dissociative Postures”[All fields] OR “Hysterical 
Postures”[All fields] OR “Functional Posturing”[All fields] OR “Psychogenic Posturing”[All fields] OR “Conversion Posturing”[All 
fields] OR “Conversive Posturing”[All fields] OR “Dissociative Posturing”[All fields] OR “Hysterical Posturing”[All fields] OR 
“Functional Bradykinesia”[All fields] OR “Psychogenic Bradykinesia”[All fields] OR “Conversion Bradykinesia”[All fields] OR 
“Conversive Bradykinesia”[All fields] OR “Dissociative Bradykinesia”[All fields] OR “Hysterical Bradykinesia”[All fields] OR 
“Functional Akinesia”[All fields] OR “Psychogenic Akinesia”[All fields] OR “Conversion Akinesia”[All fields] OR “Conversive 
Akinesia”[All fields] OR “Dissociative Akinesia”[All fields] OR “Hysterical Akinesia”[All fields] OR “Functional Slowness”[All 
fields] OR “Psychogenic Slowness”[All fields] OR “Conversion Slowness”[All fields] OR “Conversive Slowness”[All fields] OR 
“Dissociative Slowness”[All fields] OR “Hysterical Slowness”[All fields] OR “Functional Gait”[All fields] OR “Psychogenic 
Gait”[All fields] OR “Conversion Gait”[All fields] OR “Conversive Gait”[All fields] OR “Dissociative Gait”[All fields] OR 
“Hysterical Gait”[All fields] OR “Functional Walking”[All fields] OR “Psychogenic Walking”[All fields] OR “Conversion 
Walking”[All fields] OR “Conversive Walking”[All fields] OR “Dissociative Walking”[All fields] OR “Hysterical Walking”[All 
fields]) AND (“Biomarkers”[All fields] OR “Biomarker”[All fields] OR “Magnetic Resonance Imaging”[All fields] OR “MRI”[All 
fields] OR “Functional magnetic resonance imaging”[All fields] OR “fMRI”[All fields] OR “Functional neuroimaging”[All fields] 
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OR “Positron-Emission Tomography”[All fields] OR “PET”[All fields] OR “Single-Photon Emission-Computed Tomography”[All 
fields] OR “Single photon emission computerized tomography”[All fields] OR “SPECT”[All fields] OR “Computed 
Tomography”[All fields] OR “CT”[All fields] OR “Neuroimaging”[All fields] OR “Imaging”[All fields] OR 
“Electroencephalography”[All fields] OR “EEG”[All fields] OR “Electromyography”[All fields] OR “EMG”[All fields] OR 
“Neurophysiology”[All fields] OR “Electrophysiology”[All fields] OR “Evoked potentials”[All fields] OR “Evoked potential”[All 
fields] OR “Movement control”[All fields] OR “Motor control”[All fields] OR “Brain activity”[All fields] OR “Transcranial magnetic 
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Supplementary table 1. Studies on Biomarkers in Functional Movement Disorders 
 










































shoulder level,  
with 500 g 
mass attached 












A test battery which was 
calculated to a number of points 
(maximum 10) could 
differentiate functional and 
organic tremor. The sensitivity 
and sensitivity of the test battery 



























Patients with FMD had a 
significantly higher score on the 
test battery compared to patients 
with organic tremor. The 
sensitivity was 90 % and the 
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gram loading at 
wrists, during 









































, EMG and 
video at rest 















Increased amplitude upon 
loading had a sensitivity of 22 % 
and a specificity of 92 %. 
Entrainment had sensitivity of 
91 % and a specificity of 91 %. 
Distractibility had a sensitivity 
of 94 % and a specificity of 92 



































with one hand 
and with the 
other hand at 












The reaction time task resulted 
in reduction in amplitude or 
cessation in the contralateral 
hand in patients with functional 
tremor and healthy controls 
mimicking tremor but not in 
patients with PD or ET. The test 
had a sensitivity and specificity 
of both 100 % in differentiating 
healthy controls and patients 
with functional tremor from 
patients with organic tremor. 
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9 None To explore 
the 
concordanc


















and action as 

















A combination of clinical, 
electrophysiological and [123I]-
FP-CIT SPECT investigations 
improved the diagnostic 
accuracy to differentiate 
between pure functional 
parkinsonism from a combined 
functional parkinsonism and 




































Coherence was significantly 
larger in functional tremor, PD 
and ET patients 
than in EPT patients. 
A more synchronous pattern was 
predominant in PD, EPT and 
functional tremor compared to a 
predominantly alternating 
activity in ET. 
EPT patients showed significant 
low coherence which could 
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differentiate it from the other 
types of tremor with a sensitivity 
of 89% and a specificity of 80%. 
Frequency variability was 
significant in functional tremor 



















































A tree-based statistical algorithm 
based on objective data 
from computerized tremor 
recordings could differentiate 
functional and organic tremor. 
The model was based on 
amplitude and frequency at rest, 
with extended arms, and during 
finger-to-nose movements. The 
sensitivity of the test was 87 % 













































The coherence entrainment test 
was sensitive and specific in 
distinguishing functional and 
organic tremors. 
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Functional tremor was 
characterized by both agonistic 
and antagonistic muscle 
contractions, alternating 
patterns, variable amplitude and 





























hand at the 
same 







In patients with functional 
tremor the tremor paused or 
changed frequency when tapping 
with the other hand. 
Furthermore, the tremor 
involved fewer limb segments, 
was less consistent, and the 
frequency of the most consistent 
tremor was higher than the 


































Patients with functional tremor 
differed from patients with 
organic tremor by having 
inconsistent tremor, cease in 
tremor during distractions 
(sensitivity 86 %), and absence 
of finger tremor (sensitivity 100 
%). The EMG and accelerometer 
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with 1000 g 
loading. 
measures showed a coactivation 
of muscles preceding tremor 
(sensitivity 100 %, specificity 
100 %), and increased tremor 
amplitude during loading 
(sensitivity 69 %, sensitivity 75 
































Functional tremor could be 
distinguished from organic types 
of tremor by a higher number of 












































examination is a useful tool in 
the diagnosis of different types 
of tremor. Functional tremor was 
characterized by a large 




















Seven of 15 patients showed 
coherency between the two 
hands while 8 patients had 
independent oscillations. 
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Voluntary bilateral tremor 
typically results in coherence 
between the two hands. The 
absence of coherence might be 
due to nonvoluntary mechanism 


























the use of 
polymyogra





















Polymyography was a useful 
tool in supporting the clinical 
diagnosis of FMD as well as 
differentiating functional and 
organic tremor. 



































Patients with functional tremor 
showed increased activity in 
anterior cingulate/paracingulate 
cortex during the emotion face 
recognition task compared to 
healthy controls at baseline. 
In patients tremor severity 
improved and the activity in 
anterior cingulate/paracingulate 
cortex decreased after cognitive 
behavioural therapy. 
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Right temporoparietal junction 
hypoactivity during functional 
tremor compared to voluntary 
tremor. The right 
temporoparietal junction has 
been linked to general 














































Patients with functional tremor 
showed increased activity in the 
right cerebellum during motor 
task. 
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Patients with functional tremor 
showed increased rCBF in the 
left inferior frontal gyrus and left 
insula at rest compared to 
healthy controls. During the 
motor task rCBF was increased 
in the cerebellum and reduced in 
the left anterior cingulate cortex, 
and bilateral ventral medial 
prefrontal cortex compared to 
resting state. In patients with 
functional tremor the default 
mode network was deactivated 
during movements. 








































The test was 
performed in a 
resting state 
while the other 
hand was not 
trembling and, 






The reaction time was 
significantly different between 
the resting state and the 
trembling state test in the FMD 
and healthy controls groups but 
not in the PD and ET group. 
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relative to a 
clock. They 
were asked to 
judge the 








The sense of volition preceding 
movement 
was impaired in patients with 
functional tremor suggesting that 
voluntary actions might be 
experienced as involuntary. 


























TMS and MEP 
of the abductor 
pollicis brevis 







Cortical plasticity was abnormal 
in patients with organic dystonia 
but normal in patients with 





























Fixed dystonia in patients with 
complex regional pain syndrome 
type 1is not associated with 
abnormal sensorimotor plasticity 
and therefore shares 
pathophysiology with functional 
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during rest and 
during a 
reaction time 





in the opposite 
direction to the 
habitual 
posture. 





Patients with acquired dystonia 
had a longer reaction time 
compared to patients with 
functional dystonia. Patients 
with functional dystonia had less 
co-contraction than patients with 
acquired dystonia. 
Although significant differences 
were found, the overlap was 
large which made the tests less 
































Short intracortical inhibition was 
reduced and contralateral silent 
period was shorter in organic 
and functional dystonia 
compared to healthy controls.  
Abnormal cortical excitability 
might predispose to both organic 
and functional dystonia. 
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TMS MEP amplitude Pathop
hysiolo
gy 
Cortical inhibition was 
reduced in both functional and 
organic dystonia. Cutaneous 
silent period was increased in 
functional and organic dystonia. 
Spinal reciprocal inhibition was 
reduced in only functional 
dystonia. Functional and organic 
dystonia share similar 
physiological abnormalities 
which might indicate that the 
findings are a result of the 
abnormal posture itself or that 
the functional and organic 






























and test the 























Patients with functional dystonia 
had increased activity in the 
cerebellum and basal ganglia 
and decreased activity in the 
primary motor cortex compared 
to healthy controls and patients 
with organic dystonia during all 
tasks. During movement 
compared to rest the right 
dorsolateral prefrontal cortex 
was activated in organic and 
functional dystonia but not in 
healthy controls. 
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No difference was found in brain 
activity during the motor task. 






























Normal cortical volumes were 
found 
in both functional dystonia 
groups, 
but atrophy of the orbitofrontal, 
parietal, and cingulate 
cortex, hippocampus, and globus 
pallidus was seen in patients 
with mobile functional dystonia 
compared to fixed functional 
dystonia. Atrophy of the basal 
ganglia and thalamus was found 
in patients with mobile 
functional dystonia compared to 
healthy controls. Severe 
disruption of white matter tract 
architecture involved with 
cognitive, emotional, and motor 
pathways was observed in fixed 
mobile dystonia compared to 
healthy controls and patients 
with mobile functional dystonia. 
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threshold was higher bilaterally 
in patients with functional and 
primary torsion dystonia 
compared to healthy controls. In 
patients with unilateral affection 
no difference in temporal 
discrimination threshold was 







































In patients with mobile dystonia 
abnormal 
mental rotation and temporal 
discrimination threshold were 
found. In patients with fixed 
dystonia only mental 
rotation was impaired compared 
to healthy controls. 
The deficits found might be due 
to the abnormal body posture 
itself, a shared 
predisposing pathophysiology 
for mobile and fixed dystonia, 
or a body image disturbance. 
Myoclonu
s 


















EEG and EMG BP and ERD Diagno
stic 
A significant BP was present in 
25 % and a significant ERD was 
present in 65 % of patients with 
functional the propriospinal 
jerks. BP and ERD was absent in 
the healthy controls group. 
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EEG BP and ERD Diagno
stic 
An objective BP had a 
sensibility of 51 % and a 
specificity of 100 %. ERD had a 
sensitivity of 62 % and a 
specificity of 100 %. The 
combination of BP and ERD had 
a sensitivity of 76 % and a 





























Patients with FMD had BP 
before their jerk significantly 
more often than healthy controls 
and organic myoclonus. The 
absence of a BP before intended 
movement had a sensitivity of 
59 % and a specificity of 98 % 
for functional myoclonus. 
Terada 
[52] 










can be used 
to diagnose 
EEG and EMG BP Diagno
stic 
A BP before a functional jerk 
was seen in five out of six 
patients (sensitivity 67 %). A BP 
before a voluntary mimicked 
jerk was seen in two out of six 
patients. 
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31 patients were clinically 
diagnosed as propriospinal 
myoclonus and 34 as functional 
myoclonus. EEG and EMG 
showed that all patients had 
either a BP (86%) and/or an 
incongruent pattern on EMG (85 
%) and could therefore be 
categorized as functional 
myoclonus. Clinical evaluation 
was unreliable in differentiate 
propriospinal myoclonus from 



























the use of 
















EEG showed definite BP in 6 
patients (30%), possible BP in 9 
patients (45%), and 
an absent BP in 5 patients 
(25%). The two movement 
disorder specialists agreed 75 % 
of the times. The agreement 
between the clinical and 
electrophysiologic examination 
was 90 %. 
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van der 
Salm[56] 
































of psychogenic axial jerks was 
made based on clinical clues in 8 
cases, on inconsistent 
findings at polymyography in 
15, on observations of regular 
eye blinking 
preceding jerks in 2, and on 
presence of a 



































108 dB loud 
tones. 





Patients with functional 
myoclonus showed enlarged 
response probability of the early 
and late response. The early 
response was enlarged, but 
normally patterned. The late 
response was more variable 
patterned compared to healthy 
controls. 
The high response probability 
corresponds to a hypersensitivity 
to external stimuli often linked 
to functional myoclonus. The 
enlarged response frequency of 





























confirmed the diagnosis of 
myoclonus in 74% and its 
subtype 
in 78% of cases. 
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myoclonus 
and functio



























































EMG and EEG BP Diagno
stic 
First impression of the patients 
was decisive 
in 18.5% of cases, medical 
history in 33.3%, neurologic 
examination in 39.7%, BP in 
8%, and the psychiatric 
interview in 0.5%. Medical 
history resulted in a diagnostic 
switch in 34.5 % of cases, 
neurologic examination in 
13.8%, BP in 7.2%, and 
psychiatric evaluation in 2.7%. 






































The test had a 100 % sensitivity 
and specificity. 
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Brum[59] 2015 Clinical 









































In healthy controls voluntary 
contraction causes shortening of 
MEP latency, increasing MEP 
amplitude and longer MEP 
duration.  
In patients with suspected FMD 
no increase in MEP duration was 
found. This was not seen in any 
of the other patient groups. The 
phenomenon could be due to 
voluntary lack of alpha motor 
neuron activation. 





































The MEP amplitude increased in 
healthy controls and patients 
with ALS but not obviously in 
some patients with FMD. A 
large intrasubject variance 
among trials were seen in the 
FMD group especially during 
the cue signal paradigm which 
had a high specificity in 
differentiating patients with 
FMD from healthy controls and 
patients with ALS. 
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At rest the motor threshold and 
MEP amplitudes were almost 
identical in the patients and 
healthy controls. At motor 
imagery MEP amplitudes 
increased by 200 % in healthy 
controls but only by 63 % in 
patients imagining moving the 
nonaffected finger and decreased 
by 37 % when imagining 































In healthy controls motor 
imagery resulted in an increase 
of corticospinal excitability 
while a decrease was seen in 
patients when imagining moving 


































During motor imagery MEPs 
were significantly smaller in 
patients compared to healthy 
controls. Compared to rest, 
motor imagery resulted in an 
increase of MEPs in healthy 
controls but a decrease in 
patients with functional paresis. 
During motor observation no 
significant difference was seen. 
Moving the focus of attention 
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paresis. away from the patient could be a 
possible therapeutic approach. 
Blakemore
[64] 



















































Patients with FMD and healthy 
controls feigning paresis showed 
similar reduced force, longer 
movement time and extended 
duration of muscle activity in the 
symptomatic limb. Patients had 
significantly suppressed 
contingent negative variation 
amplitude when the limb was 
precued which was not seen in 







































When the symptomatic hand was 
precued, the P3 event-related 
potential component 
companying the precue was 
dramatically larger in patients 
with functional paresis 
compared to feigning healthy 
controls. Also, the earlier N1 
event-related potential 
component was diminished 
when the precue signaled either 
the symptomatic or 
asymptomatic hand. These 
results might indicate a 
suppression of brain activity 
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Anterior cingulate cortex was 
hyperactive during movements 
initiated in the paretic compared 

































Variability of torque could be 
seen in 22 patients. 
Higher torque in fast compared 
to slow movements was found in 
8 patients. 
A smaller force production than 
expected from the weight of the 
leg and lever arm due to 
restraining activation of the 
quadriceps muscle was observed 
in 12 patients. 
The torque recording could 
support the diagnosis of 
functional paresis. 
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During simultaneous emotional 
stimulation and passive 
movement of the affected hand 
patients with functional paresis 
showed hyperactivity in the left 
amygdala. 
Psychophysiological interaction 
revealed increased functional 
connectivity between the left 
amygdala and the (pre-
)supplemental motor area and 
subthalamic nucleus in patients 
with functional paresis. These 
areas are involved in motor 
control networks. 












































During passive movement of the 
affected arm patients with FMD 
showed activation of the 
bilateral triangular part of the 
inferior frontal gyri with a left 
side dominance compared to 
non-feigning controls. Feigning 
controls had increased activation 
of the right triangular part of 
inferior frontal gyri and a 
decreased activation in the 
medial prefrontal cortex 
compared to non-feigning 
controls. This suggests that the 
self-agency in patients with 
FMD is in between the feigning 
and non-feigning condition in 
healthy controls. 
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in a 0.5 Hz 
pace of the 








Patients with functional paresis 
showed abnormal parietal 
function. Patients also had 
reduced activity in the prefrontal 










r cortex in 
conversion 
paralysis. 

























Strong functional connectivity 
between the dorsolateral 
prefrontal cortex and several 
sensorimotor areas which was 
more pronounced when patients 
imagined the affected hand 





















connectivity in default-mode 
network. 
Decreased inter-connectivity 
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between default-mode network 
and limbic/salience network, 
temporo-parieto-occipital 
junction, and medial temporal 
lobe and medical temporal lobe 
and sensorimotor network. 
Increased connectivity between 
limbic/salience network and 
temporo-parieto-occipital 
junction and between 
hippocampus and the default-
mode network. Networks related 
to memory, emotion, self-
referential processing, motor 
planning, and execution were 
disturbed. 




























In both patients and healthy 
controls feigning paresis reduced 
activation of the motor cortex 
contralateral to the affected or 
simulated affected limb was seen 
compared to the nonaffected 
limb.  
In patients with functional 
paresis activation was seen in 
the putamen and lingual gyri 
bilaterally, left inferior frontal 
gyrus, left insula, and 
deactivated 
right middle frontal and 
orbitofrontal cortices. Only 
controls simulating weakness 
activated the contralateral 
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Only when imagining of moving 
the affected arm recruitment of 
the ventromedial prefrontal 
cortex and superior temporal 
cortex was seen. This might be 
due to heightened self-











of the motor 
system. 
7 None To examine 
how motor 
imagery can 















by a motor 
imagery task 
where subjects 




Significant increased activity in 
dorsal parietal and 
premotor cortex with increasing 
rotation was both during implicit 
and explicit motor imagery. 
Superior and medial 
portions of the frontal cortex, the 
gyrus rectus and superior 
temporal cortex showed 
greater cerebral activity for the 
affected hand than the 
unaffected hand during implicit 
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Patients with functional paresis 
showed 
decreased activation of cortical 
hand areas during movement 
observation compared to healthy 
controls. 
This effect was specific to the 
side of their paralysis. 
Brain activation compatible with 
movement inhibition was not 
observed. 





































Increased regional homogeneity 
in the left precentral gyrus and 
reduced regional homogeneity in 
the precuneus contralateral to the 
hemiparetic side. Mean short-
interval intra-cortical inhibition-
facilitation was increased in 
FMD. These structures are 
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The last scan 
was repeated 












The regional cerebral blood flow 
during vibratory stimulation was 
reduced  
in the thalamus and the basal 
ganglia contralateral to the 
deficit. 



















PET Brain activity Pathop
hysiolo
gy 
Decreased cerebral blood flow 
was seen in cortical frontal 
regions corresponding 





























Patients with FMD had a 
significantly smaller left 
thalamic volume and borderline 
significantly smaller right 
thalamic volume compared to 
controls. This difference could 
be a primary disease process or a 
secondary effect as a result of 
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Patients with functional 
hemiparesis showed bilaterally 
increased grey matter thickness 
of the premotor cortex compared 
to healthy controls. 
No differences were found in the 
patients with paraparesis. 






















































The involuntary/voluntary force 
ratio on the affected limb was 
significantly larger in patients 
with functional paresis 
compared to healthy controls 
and patients organic paresis. 
Futhermore, the ratio of 
involuntary/voluntary force ratio 
between the affected and non-
affected side was more than nine 
times larger in functional paresis 
compared to the other groups. 
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The involuntary/voluntary force 
ratio on the affected limb and the 
ratio of the 
involuntary/voluntary force ratio 
of the two sides were 
significantly larger in patients 
with functional paresis 
compared to healthy controls 
and patients with stroke and 
paresis due to pain. The test had 
a sensitivity and specificity of 





























during a “make 
test” (static 
contraction) 














In healthy controls there was 
only a small increase (3 %) in 
motor contraction in the “break” 
compared to “make” test. The 
difference was slightly larger (6 
%) in patients with organic 
paresis and considerably larger 
(68 %) in patients with 
functional paresis. Patients with 
functional paresis had a larger 
effect of encouragement 
compared to the other groups 
and showed an increasing force 
during the tests. 
Based on the data a cut off value 
of 20 % improvement of force 
during “break” compared to 
“make” and during 
encouragement was used to test 
the patients with a blinded 
diagnosis. Three patients had 
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organic paresis and 17 had 
functional paresis. In 19 out of 
20 patients the diagnosis was 
confirmed using these criteria. 
One patient with organic paresis 
fulfilled the criteria for 
functional paresis. This 
corresponds to a sensitivity of 








































Reaction time but not response 
duration was impaired 
suggesting that the motor 
initiation was affected. 
          































Patients with FMD lacked 
attenuation of SEPs at the onset 
of movement whereas healthy 
controls showed reduction in 
amplitude of SEPs. This may 
indicate that patients have an 
impaired sense of agency for 
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Movement 
Disorders. 









































Opposite healthy controls, 
patients with FMD did not 
improve in reaction time with 
highly predictive cues and 
showed impairment of beta 
desynchronization and 
lateralization before movement. 
This may reflect attention 
towards the movement itself 

































Patients with FMD had 
hyperconnected right caudate, 
left amygdala and bilateral 
postcentral gyri. Decreased 
functional connectivity was 
found in the right 
temporoparietal junction and 
frontal areas. 
A model was made to 
distinguish FMD and healthy 
controls. The model had an 
accuracy, specificity and 
sensitivity all above 68 %. 
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Patients with FMD had 
decreased functional 
connectivity between the right 
temporoparietal junction and the 
right sensorimotor cortex, 
cerebellar vermis, bilateral 
supplementary motor area and 
right insula compared to healthy 
controls. Temporoparietal 
junction is involved in self-
agency and the results might 
explain why patients of FMD 
experience their movements as 
involuntary. 































tasks with their 
right hand in a 
virtual reality 
where subjects 
could see the 
hand 
movement on a 
screen. 
Sometimes the 












The dorsolateral prefrontal 
cortex and the pre-
supplementary motor area on the 
right did not respond differently 
to the loss of movement control 
indicating a dysfunction of the 
sense of agency neural network. 
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intermediate. 
































Both during internally and 
externally generated movements 
FMD patients had lower activity 
in left supplementary motor area 
(implicated in motor initiation) 
and higher activity in right 
amygdala, left anterior insula, 






















When subjects rated the 
deviation and confidence of their 
response healthy controls 
engaged the left superior 
precuneus and middle temporal 
region which are involved in 
sensory-motor integration and 
vision whereas FMD patients 
recruited bilateral 
parahippocampal and amygdalo-
hippocampal regions which are 
related to memory, emotions, 
and contextual associative 
processing. 
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The force output decayed for 
healthy controls when looking at 
both pleasant and unpleasant 
pictures while the patients FMD 
showed decayed force when 
looking at pleasant pictures but 
maintained the force when 
looking at unpleasant pictures 
indicating a pronounced effect of 
negative effect on force output. 
When looking at unpleasant 
pictures healthy controls had 
increased activity in the inferior 
frontal cortex and pre-
supplementary motor area 
whereas patients with FMD had 
increased activity in the 
cerebellum, posterior cingulate 
cortex and hippocampus. This 
might indicate that 
psychological stressors result in 




























Decreased perfusion was seen in 
the left temporal lope in two 
patients, in the bilateral temporal 
lopes in one patient, in the left 
parietal lope in one patient, and 
in the left temporal and parietal 
lope in one patient.  The left 
hemisphere was dominant in all 
patients. 
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Maurer 
[92] 





















Increased volume of the left 
amygdala, 
left striatum, left cerebellum, left 
fusiform gyrus, and bilateral 
thalamus, and decreased volume 
of the left sensorimotor cortex in 
FMD. These structures are 






























Patients had significantly 
smaller volumes of the bilateral 
caudate nuclei, lentiform nuclei, 
and right thalamus compared to 
healthy controls. 
Age at disease onset showed a 
significant relation with left 
caudate volume. 



















The motor response inhibition in 
patients with FMD was impaired 
compared to healthy controls. 
The result remained significant 
after 
controlling for attention, 



















Motor task was 
performed 
(action) 








An effect following a voluntary 
action was perceived as 
happening earlier and the action 
later compared to tests of only 
motor action or tones. Patients 
with FMD had reduced action-
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disorder: 
implications 
for sense of 
agency. 
with FMD. completing 
where high, 
medium and 











effect binding scores compared 
to healthy controls. The 

















































Healthy controls showed 
significant potentiation of startle 
responses by negative pictures 
and a tendency of inhibition by 
positive pictures. In patients 
with FMD both negative and 
positive pictures resulted in a 
larger startle response compared 
to neutral pictures. Depression 
and anxiety did not correlate 
with the startle response. The 
abnormal startle response 
modulation might be useful in 






















FMD patients had increased 
values of trunk angular velocity 
compared to MS patients and 
healthy controls which had a 
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written on their 
back). 
sensitivity of 92 % and a 
specificity of 92 %. 
Furthermore, a significant effect 
of distractibility was found 
which had a 100 % sensitivity 
and 100 % specificity. This test 
can be used to confirm a positive 
diagnose of FMD. 















































Patients with FMD showed 
larger body sway compared to 
healthy controls. In healthy 
controls, body sway decreased 
over time during exposure to 
stress whereas it was stable in 
patients with FMD. Complexity 
of movement pattern over time 
was lower in patients in FMD 
compared to healthy controls. 























Compared to healthy controls, 
patients with FMD showed a 
larger decrease of static balance 
when eyes where closed 
compared to opened. Cognitive 
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distractions improved static 
balance in patients with FMD 
but decreased balance in healthy 
controls. 
          
 
Legend: Abbreviations: FMD functional movement disorder, MRI magnetic resonance imaging, fMRI functional magnetic resonance 
imaging, PET positron emission tomography, SPECT single-photon emission computed tomography, BOLD blood oxygenation level 
dependent, rCBF relative cerebral blood flow, EEG electroencephalography, EMG electromyography, ERD event related 
desynchronization, BP bereitschaftspotential, PD Parkinson’s disease, ET essential tremor, EPT enhanced physiologic tremor, MS 
multiple sclerosis, ALS amyotrophic lateral sclerosis, TMS transcranial magnetic stimulation, MEP motor evoked potential, SEP 
sensory evoked potential. 
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